BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11046074)

  • 1. Multiple central nervous system targets for eliciting beneficial effects on memory and cognition.
    Buccafusco JJ; Terry AV
    J Pharmacol Exp Ther; 2000 Nov; 295(2):438-46. PubMed ID: 11046074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging cognitive enhancing drugs.
    Buccafusco JJ
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):577-89. PubMed ID: 19772371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of JWB1-84-1 on memory-related task performance by amyloid Abeta transgenic mice and by young and aged monkeys.
    Sood A; Warren Beach J; Webster SJ; Terry AV; Buccafusco JJ
    Neuropharmacology; 2007 Oct; 53(5):588-600. PubMed ID: 17698153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug targets for cognitive enhancement in neuropsychiatric disorders.
    Wallace TL; Ballard TM; Pouzet B; Riedel WJ; Wettstein JG
    Pharmacol Biochem Behav; 2011 Aug; 99(2):130-45. PubMed ID: 21463652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive dysfunction in neuropsychiatric disorders: selected serotonin receptor subtypes as therapeutic targets.
    Terry AV; Buccafusco JJ; Wilson C
    Behav Brain Res; 2008 Dec; 195(1):30-8. PubMed ID: 18241938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropharmacology of cognition and memory: a unifying theory of neuromodulator imbalance in psychiatry and amnesia.
    Vakalopoulos C
    Med Hypotheses; 2006; 66(2):394-431. PubMed ID: 16300905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine.
    Riepe MW; Adler G; Ibach B; Weinkauf B; Tracik F; Gunay I
    Dement Geriatr Cogn Disord; 2007; 23(5):301-6. PubMed ID: 17356273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memory-related task performance by aged rhesus monkeys administered the muscarinic M(1)-preferring agonist, talsaclidine.
    Terry AV; Buccafusco JJ; Borsini F; Leusch A
    Psychopharmacology (Berl); 2002 Jul; 162(3):292-300. PubMed ID: 12122487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid, cholinesterase, melatonin, and metals and their roles in aging and neurodegenerative diseases.
    Lahiri DK; Chen DM; Lahiri P; Bondy S; Greig NH
    Ann N Y Acad Sci; 2005 Nov; 1056():430-49. PubMed ID: 16387707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the trail of a cognitive enhancer for the treatment of schizophrenia.
    Stip E; Chouinard S; Boulay LJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):219-32. PubMed ID: 15694228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention.
    Kidd PM
    Altern Med Rev; 2008 Jun; 13(2):85-115. PubMed ID: 18590347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel cognitive improving and neuroprotective activities of Polygala tenuifolia Willdenow extract, BT-11.
    Park CH; Choi SH; Koo JW; Seo JH; Kim HS; Jeong SJ; Suh YH
    J Neurosci Res; 2002 Nov; 70(3):484-92. PubMed ID: 12391609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT(7) receptors in the modulation of cognitive processes.
    Cifariello A; Pompili A; Gasbarri A
    Behav Brain Res; 2008 Dec; 195(1):171-9. PubMed ID: 18243350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolyl oligopeptidase: a potential target for the treatment of cognitive disorders.
    Männisto PT; Venäläinen J; Jalkanen A; García-Horsman JA
    Drug News Perspect; 2007 Jun; 20(5):293-305. PubMed ID: 17878957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease.
    Wright JW; Harding JW
    J Renin Angiotensin Aldosterone Syst; 2008 Dec; 9(4):226-37. PubMed ID: 19126664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of melatonin or 17 beta-estradiol on improving spatial memory performance in cognitively impaired, ovariectomized adult rats.
    Feng Z; Cheng Y; Zhang JT
    J Pineal Res; 2004 Oct; 37(3):198-206. PubMed ID: 15357665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chinese herbal medicine for Mild Cognitive Impairment and Age Associated Memory Impairment: a review of randomised controlled trials.
    May BH; Yang AW; Zhang AL; Owens MD; Bennett L; Head R; Cobiac L; Li CG; Hugel H; Story DF; Xue CC
    Biogerontology; 2009 Apr; 10(2):109-23. PubMed ID: 18716893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of donepezil on memory and cognition in multiple sclerosis.
    Christodoulou C; Melville P; Scherl WF; Macallister WS; Elkins LE; Krupp LB
    J Neurol Sci; 2006 Jun; 245(1-2):127-36. PubMed ID: 16626752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.